
Mexico’s Federal Economic Competition Commission (COFECE) announced on Thursday it had determined to sanction AT&T and Warner Bros. Discovery with a fine for failing to disclose their concentration, related to the separation of Warnermedia’s business ventures in Mexico.
The competition regulator revealed the fine would total more than 51 million pesos ($2.5 million), a calculation based on both the severity of the violation and on the size of the overall transaction.
The sanction is related to an international merger operation, in which the acquisition by Discovery, Inc. of AT&T’s business known as Warnermedia was originally proposed. This merger would have included Warner’s Mexican business, including Warner Media Mexico and Warner HBO.
Read More: WarnerMedia, Discovery Complete Tie-Up
Mexican telecommunications regulator, the Instituto Federal de Telecomunicaciones, had also imposed some conditions on their approval of the merger operation, relating to specific services and channels carried by the networks. In particular, the companies committed to minimizing the concentration’s impact on their popular children’s For Pay programming, including the Cartoon Network and Discovery Kids! channels.
The deal would have also covered the purchase by AT&T shareholders of 71 percent of the company’s stock, resulting in a new company rebranded as Warner Bros. Discovery, Inc.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Rumble Adds David Boies to Legal Team in $2 Billion Antitrust Battle with Google
May 14, 2025 by
CPI
China Summons Delivery Giants Over Unfair Competition Concerns
May 13, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas